$38.07B
Revenue
$4.88B
Net Income
19.79%
Gross Margin
3.65%
Op. Margin
$5.85B
Free Cash Flow
| Breakdown | TTM (Dec 31, 2025) |
FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
|---|---|---|---|
| Total Revenue | $38.07B | $38.07B | $34.94B |
| Revenue Growth % | 0.0% | 9.0% | nan% |
| Cost of Revenue | $30.53B | $30.53B | $28.85B |
| Gross Profit | $7.54B | $7.54B | $6.08B |
| Gross Margin % | 19.8% | 19.8% | 17.4% |
| Research & Development | $1.20B | $1.20B | $982.00M |
| Selling General & Admin | $4.95B | $4.95B | $4.63B |
| Operating Income | $1.39B | $1.39B | $471.00M |
| Operating Margin % | 3.6% | 3.6% | 1.3% |
| Interest Expense | - | $53.00M | $74.00M |
| Other Income/Expense | $795.00M | $795.00M | $1.37B |
| Income Before Tax | $2.83B | $2.83B | $2.50B |
| Income Tax Expense | $-2.05B | $-2.05B | $939.00M |
| Net Income | $4.88B | $4.88B | $1.55B |
| Net Margin % | 12.8% | 12.8% | 4.4% |
| Basic EPS | nan | 17.92 | 5.65 |
| Diluted EPS | nan | 17.69 | 5.58 |
| Basic Shares Outstanding | -1.0M | 272.0M | 275.0M |
| Diluted Shares Outstanding | -1.0M | 276.0M | 278.0M |
| Breakdown | FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
|---|---|---|
| Accounts Receivable | $9.80B | $8.18B |
| Inventory | $10.43B | $8.59B |
| Other Current Assets | $1.45B | $562.00M |
| Total Current Assets | $40.22B | $34.15B |
| Goodwill | $4.44B | $4.26B |
| Intangible Assets | $727.00M | $813.00M |
| Other Non-current Assets | $4.09B | $2.76B |
| Total Assets | $63.02B | $51.48B |
| Short-term Debt | $63.00M | $60.00M |
| Deferred Revenue | $25.77B | $17.59B |
| Other Current Liabilities | $6.31B | $5.50B |
| Total Current Liabilities | $40.97B | $31.68B |
| Deferred Tax Liabilities | $1.16B | $827.00M |
| Other Non-current Liabilities | $5.42B | $5.12B |
| Total Liabilities | $50.72B | $40.89B |
| Common Stock | $3.00M | $3.00M |
| Retained Earnings | $6.15B | $1.61B |
| Total Stockholders Equity | $11.18B | $9.55B |
| Total Liabilities & Equity | $63.02B | $51.48B |
| Breakdown | TTM (Dec 31, 2025) |
FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
|---|---|---|---|
| Net Income | $4.88B | $4.88B | $1.55B |
| Change in Inventory | $2.75B | $1.43B | $641.00M |
| Operating Cash Flow | $7.68B | $4.99B | $2.58B |
| Capital Expenditure | $1.82B | $1.28B | $883.00M |
| Investing Cash Flow | $-1.06B | $-755.00M | $-37.00M |
| Stock Repurchased | $6.00B | $3.32B | $43.00M |
| Dividends Paid | $483.00M | $275.00M | - |
| Financing Cash Flow | $-6.93B | $-3.81B | $3.65B |
| Net Change in Cash | $234.00M | $644.00M | $6.05B |
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing
Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | $9.97B | $8.91B | $27.11B | $24.38B |
| Cost of Revenue | $8.07B | $7.80B | $21.90B | $20.41B |
| Gross Profit | $1.90B | $1.11B | $5.21B | $3.96B |
| Research & Development | $310.00M | $243.00M | $832.00M | $717.00M |
| Selling General & Admin | $1.22B | $1.23B | $3.59B | $3.37B |
| Operating Income | $366.00M | $-359.00M | $787.00M | $-122.00M |
| Other Income/Expense | $221.00M | $71.00M | $455.00M | $1.02B |
| Income Before Tax | $746.00M | $-122.00M | $1.72B | $1.39B |
| Income Tax Expense | $293.00M | $-23.00M | $514.00M | $310.00M |
| Net Income | $452.00M | $-96.00M | $1.22B | $1.07B |
| Basic EPS | 1.66 | -0.35 | 4.47 | 3.90 |
| Diluted EPS | 1.64 | -0.35 | 4.41 | 3.85 |
| Basic Shares Outstanding | $272.00M | $275.00M | $273.00M | $274.00M |
| Diluted Shares Outstanding | $275.00M | $275.00M | $277.00M | $277.00M |
Condensed Consolidated Balance Sheets
| Description | Sep 30, 2025 | Dec 31, 2024 |
|---|---|---|
| Accounts Receivable | $7.37B | $8.18B |
| Inventory | $10.03B | $8.59B |
| Other Current Assets | $934.00M | $564.00M |
| Total Current Assets | $36.28B | $34.15B |
| Goodwill | $4.33B | $4.26B |
| Intangible Assets | $747.00M | $813.00M |
| Other Non-current Assets | $3.41B | $2.76B |
| Total Assets | $54.40B | $51.48B |
| Deferred Revenue | $20.15B | $17.59B |
| Other Current Liabilities | $5.50B | $5.50B |
| Total Current Liabilities | $35.27B | $31.68B |
| Deferred Tax Liabilities | $820.00M | $827.00M |
| Other Non-current Liabilities | $5.38B | $5.12B |
| Total Liabilities | $44.67B | $40.89B |
| Common Stock | $3.00M | $3.00M |
| Retained Earnings | $2.63B | $1.61B |
| Total Stockholders Equity | $8.65B | $9.55B |
| Total Liabilities & Equity | $54.40B | $51.48B |
Condensed Consolidated Statements of Cash Flows
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $452.00M | $-96.00M | $1.22B | $1.07B |
| Change in Inventory | - | - | $1.05B | $1.15B |
| Operating Cash Flow | - | - | $2.51B | $1.66B |
| Capital Expenditure | - | - | $606.00M | $533.00M |
| Investing Cash Flow | - | - | $-381.00M | $138.00M |
| Stock Repurchased | - | - | $2.24B | $40.00M |
| Dividends Paid | - | - | $207.00M | - |
| Financing Cash Flow | - | - | $-2.63B | $3.49B |
| Net Change in Cash | - | - | $-258.00M | $5.24B |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.
Annual data represents full fiscal year results. FY = Fiscal Year ending.